Mike Solomonides

Mike Solomonides is currently a Project Oversight Senior Director in Neuroscience Rare Disease at PPD, where they focus on therapeutic areas including Myasthenia Gravis and Duchenne Muscular Dystrophy. Previously, they served as Operations Program Leader and Vice Director at Roche from 2016 to 2021. With extensive experience in project management at companies like Fujisawa, Biogen, and Hoffmann-La Roche, Mike has developed expertise in both rare diseases and various immunological conditions. They hold a BSc in Physiology from the University of Birmingham and a Postgraduate degree in Biochemistry from the University of Oxford.